Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call

MALVERN, Pa., March 10, 2025 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) (“Endo” or the “Company”) announced today that it has rescheduled the release of its fourth quarter and full year 2024 financial results to March 13, 2025, prior to market open. The Company will host a conference call…